chr12-47986388-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001844.5(COL2A1):c.1475G>A(p.Gly492Asp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G492V) has been classified as Pathogenic.
Frequency
Consequence
NM_001844.5 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IIInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Kniest dysplasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
- platyspondylic dysplasia, Torrance typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- spondyloepimetaphyseal dysplasia, Strudwick typeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- spondyloepiphyseal dysplasia congenitaInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia with metatarsal shorteningInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasiaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- spondyloperipheral dysplasiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Stickler syndrome type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Illumina, Orphanet, Genomics England PanelApp
- Stickler syndrome, type I, nonsyndromic ocularInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- avascular necrosis of femoral head, primary, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Legg-Calve-Perthes diseaseInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- spondyloepiphyseal dysplasia, Stanescu typeInheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- autosomal dominant rhegmatogenous retinal detachmentInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dysspondyloenchondromatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial avascular necrosis of femoral headInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple epiphyseal dysplasia, Beighton typeInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- spondylometaphyseal dysplasia, Schmidt typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- otospondylomegaepiphyseal dysplasiaInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- vitreoretinopathy with phalangeal epiphyseal dysplasiaInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL2A1 | ENST00000380518.8 | c.1475G>A | p.Gly492Asp | missense_variant | Exon 23 of 54 | 1 | NM_001844.5 | ENSP00000369889.3 | ||
COL2A1 | ENST00000337299.7 | c.1268G>A | p.Gly423Asp | missense_variant | Exon 22 of 53 | 1 | ENSP00000338213.6 | |||
COL2A1 | ENST00000493991.5 | n.399G>A | non_coding_transcript_exon_variant | Exon 6 of 37 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1417276Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 700772
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Occurs in the triple helical domain and replaces a glycine in a canonical Gly-X-Y repeat; missense substitution of a canonical glycine residue is expected to disrupt normal protein folding and function, and this is an established mechanism of disease (PMID: 34007986); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 34007986, 36307859, 20179744) -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly492 amino acid residue in COL2A1. Other variant(s) that disrupt this residue have been observed in individuals with COL2A1-related conditions (PMID: 7550321, 30130436), which suggests that this may be a clinically significant amino acid residue. This variant disrupts the triple helix domain of COL2A1. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL2A1, variants affecting these glycine residues are significantly enriched in individuals with disease (PMID: 9016532, 17078022) compared to the general population (ExAC). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL2A1 protein function. This missense change has been observed in individual(s) with clinical features of autosomal dominant Stickler syndrome (PMID: 20179744; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 492 of the COL2A1 protein (p.Gly492Asp). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at